Molecular Targeting Technology Company Profile

16:10 EDT 20th September 2017 | BioPortfolio

Molecular Targeting Technologies, Inc. (MTTI) is a privately held company engaged in the development and commercialization of unique nuclear imaging products and targeted delivery technology for diagnostic and therapeutic applications in multiple diseases. The company’s lead product, AMISCAN, is a patented myocardial infarct-imaging agent intended for the rapid and sensitive detection of diagnostically equivocal heart attacks. AMISCAN entered phase II clinical trials in the 1st quarter of 2001. The company anticipates product launch in 2004. A focused product-driven business strategy, strong corporate business alliances, and management committed to success and professional integrity afford the Company a compelling competitive position.


882 South Matlack Street, Suite 105
West Chester
United States of America


Phone: (610) 738-7938
Fax: (610) 738-7928

News Articles [2019 Associated News Articles listed on BioPortfolio]

Innovative Targeting Solutions Initiates Research Collaboration

BURNABY, BC, Jan. 19, 2012 /PRNewswire/ - Innovative Targeting Solutions Inc. (ITS), the developer of the next generation fully human antibody technology (HuTARG), today announced the initiation of...

Phoenix Molecular reports ‘breakthrough’ in early PMD-026 studies

Preclinical studies on PMD-026 targeting RSK (p90 ribosomal S6 kinase) have shown promising results, according to Phoenix Molecular Designs (PheonixMD). PMD-026 is an oral small molecule which targets...

Cardiovascular endocrinology: Is ANGPTL3 the next PCSK9?

Recent reports suggest that molecular therapies targeting ANGPTL3 and its encoded protein angiopoietin-like protein 3 have clinical potential comparable to therapies targeting PCSK9 and its encoded pr...

Molecular Diagnostics Market by Type Instruments, Reagents, and Software Services, Technology PCR, Hybridization, DNA Sequencing, Microarray, Isothermal Nucleic Acid Amplification Technology INAAT, and Others, Application Infectious Diseases, Oncology, G

Molecular diagnosis is a process of identifying a disease by studying molecules, such as proteins, DNA, and RNA, in a tissue or fluid. Molecular diagnostic tests are used to detect specific sequences ...

Researchers develop tumor-targeting MRI contrast based on human protein

A team led by Gang Han, PhD, has designed a human protein-based, tumor-targeting Magnetic Resonance Imaging (MRI) contrast that can be easily cleared by the body. The discovery holds promise for clini...

Function of cerebellar interneurons probed with new technique

Researchers have developed a technique for selectively targeting and controlling the interneurons of the cerebellar molecular layer relying on a genetically engineered mouse model that exploits a uniq...

Engineered Cpf1 variants with altered PAM specificities

The targeting range of the CRISPR endonuclease Cpf1 is increased three-fold by molecular engineering.

Comprehensive cancer study assesses potential targets for personalized medicine and finds new ones

Looking to improve cancer treatment, a multi-institutional research team has taken a comprehensive approach to evaluating which molecular changes in cancer cells are most likely involved in the develo...

PubMed Articles [4204 Associated PubMed Articles listed on BioPortfolio]

Translocator Protein PET Imaging in a Preclinical Prostate Cancer Model.

The identification and targeting of biomarkers specific to prostate cancer (PCa) could improve its detection. Given the high expression of translocator protein (TSPO) in PCa, we investigated the use o...

Cas9, Cpf1 and C2c½/3-What's next?

Since the rapid emergence of clustered regulatory interspaced short palindromic repeats (CRISPR)-CRISPR-associated protein 9 (Cas9) system, developed as a genome engineering tool in 2012-2013, most re...

AID Invited to the G4 Summit.

In this issue of Molecular Cell, Qiao et al. (2017) use both biochemical and structural approaches to report AID-preferred nucleic acid substrates, illuminating AID targeting mechanisms during CSR an...

Improvement in the prognosis of ovarian cancer in the era before addition of molecular targeting therapy.

The prognosis of ovarian cancer has improved because of platinum- and taxane-containing chemotherapy. We investigated the 5-year disease-specific overall survival and prognostic factors of patients wi...

Use of Morpholino Oligomers for Pretargeting.

Differing from the conventional direct-targeting strategy in which a probe or payload is directly loaded onto a targeting molecule that binds to the native target, pretargeting is an improved targetin...

Clinical Trials [2630 Associated Clinical Trials listed on BioPortfolio]

Trial of Erlotinib in Patients With JAK-2 V617F Positive Polycythemia Vera

The primary objective of this study is to determine the overall response rate to erlotinib in patients with polycythemia vera (PV). Response rate will be assessed by improvement in the com...

Effectiveness of Targeting Food Aid to Malnourished Children Compared to Targeting All Children Under Two Years

The objective of this study is to compare two approaches to targeting donated supplementary food to young children. The study compares the effectiveness of the widely-used curative approac...

CD22 Targeting CAR-T Therapy Against B Cell Hematological Malignancies

CD19 expression on B cell frequently lost after CD19-targeting CAR-T therapy. In present study, we construct a CD22-targeting chimeric antigen receptor to overcome this issue.

Study of Sperm Molecular Factors Implicated in Male Fertility

Sperm analysis following World Health Organization guidelines is unable to explain the molecular causes of male infertility when basic sperm parameters are within a normal range and women ...

User Evaluation of the Peristomal Skin Condition in Ostomates Using ConvaTec Moldable Technology™

The primary aim of this study is to demonstrate the maintenance of healthy peri-stomal skin over a two month period in subjects who use ConvaTec Moldable Technology™ Skin Barriers as par...

Companies [1683 Associated Companies listed on BioPortfolio]

Molecular Targeting Technology

Molecular Targeting Technologies, Inc. (MTTI) is a privately held company engaged in the development and commercialization of unique nuclear imaging products and targeted delivery technology for diagn...

Molecular Targeting Technologies, Inc.

Molecular Targeting Technologies, Inc. (MTTI) is a privately held US based Biotechnology Company founded to develop novel medical imaging products for the diagnosis of cardiovascu...

Molecular Targeting Technologies, Inc. and Medical College of Wisconsin


Genometrica Ltd was founded in 2008 for development and commercialization of innovative, unique technology platform capable of performing all major tests of molecular biology and targeting a rapid tra...

SibTech, Inc

SibTech, Inc. (Newington, CT) is a biopharmaceutical company that develops new protein-driven therapeutics and diagnostics. Our work is based on a novel technology for attaching payloads to targeting ...

More Information about "Molecular Targeting Technology" on BioPortfolio

We have published hundreds of Molecular Targeting Technology news stories on BioPortfolio along with dozens of Molecular Targeting Technology Clinical Trials and PubMed Articles about Molecular Targeting Technology for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Molecular Targeting Technology Companies in our database. You can also find out about relevant Molecular Targeting Technology Drugs and Medications on this site too.

Quick Search

Relevant Topics

Cardiology is a specialty of internal medicine.  Cardiac electrophysiology : Study of the electrical properties and conduction diseases of the heart. Echocardiography : The use of ultrasound to study the mechanical function/physics of the h...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...

Corporate Database Quicklinks

Searches Linking to this Company Record